NEW YORK (GenomeWeb) – Sygnis said today that it has signed a non-exclusive distribution agreement for its TruePrime product family with Ozyme France.

Under the terms of the agreement, Ozyme will be able to promote, market, and sell existing and future TruePrime products to molecular biologists in France.

TruePrime products combine Sygnis' recently discovered DNA primase TthPrimPol and the Phi29 polymerase, and enable the amplification of total genomic DNA from exceedingly small amounts of sample, down to the single-cell level, without requiring synthetic primers.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Researchers find that historical factors influence which genes are the most highly studied, the Atlantic reports.

The US National Science Foundation's new sexual harassment policy is to go into effect next month, according to Nature News.

Researchers report using genotyping to tie together illegal ivory shipments and trace them back to a handful of cartels, the New York Times reports.

In Nature this week: genomic ancestry analysis of Sardinians, current noncoding mutations in colorectal cancer, and more.

Sponsored by

In the last few years several molecular testing methodologies — such as immunohistochemistry, PCR, and sequencing — have been approved by the US Food and Drug Administration to aid in the management of patients with lung cancer.  

Sponsored by
Philips Genomics

This webinar will provide a first-hand look at how the Dana-Farber Cancer Center is adapting its oncology care strategy in light of the rapidly evolving molecular landscape.